DAVID GRAEME WATSON

Allopathic & Osteopathic Physicians|Hospitalist ATLANTA, GA NPI 1629255294

General Payments — all program years on this page

$2,898.39

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 154
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $426.92 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $426.9219

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $403.8924
2019 $594.7537
2020 $251.2114
2021 $288.4818
2022 $202.2912
2023 $730.8530
2024 $426.9219

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077986786 Janssen Pharmaceuticals, Inc $23.01 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077987236 Janssen Pharmaceuticals, Inc $22.22 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077987262 Janssen Pharmaceuticals, Inc $17.00 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087421552 Novartis Pharmaceuticals Corporation $21.71 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105518915 AstraZeneca Pharmaceuticals LP $17.80 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106312949 ABBVIE INC. $24.73 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132081242 PFIZER INC. $23.29 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140012548 GENZYME CORPORATION $22.33 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141769834 Merck Sharp & Dohme LLC $20.53 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143466209 UCB, Inc. $19.98 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143466214 UCB, Inc. $24.18 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143466218 UCB, Inc. $22.15 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143466222 UCB, Inc. $26.36 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145151682 Mallinckrodt Hospital Products Inc. $25.72 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145151686 Mallinckrodt Hospital Products Inc. $24.29 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153441457 Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.72 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153500761 Salix Pharmaceuticals, a division of Bausch Health US, LLC $22.95 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153527453 Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.90 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153646986 Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.05 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.